🇺🇸 Sodium Enoxaparin clexane in United States
4 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 4
Most-reported reactions
- Blood Creatinine Increased — 1 report (25%)
- Blood Urea Increased — 1 report (25%)
- Diarrhoea — 1 report (25%)
- Renal Failure Acute — 1 report (25%)
Other Cardiovascular approved in United States
Frequently asked questions
Is Sodium Enoxaparin clexane approved in United States?
Sodium Enoxaparin clexane does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Sodium Enoxaparin clexane in United States?
Cristália Produtos Químicos Farmacêuticos Ltda. is the originator. The local marketing authorisation holder may differ — check the official source linked above.